EHA Library - The official digital education library of European Hematology Association (EHA)

MULTICENTER RESULTS OF SCHWACHMAN-DIAMOND SYNDROME PATIENTS
Author(s): ,
Sule Unal
Affiliations:
Hacettepe University, Divison Of Pediatric Hematology,Ankara,Turkey
,
Neslihan Kalkan
Affiliations:
Hacettepe University, Divison Of Pediatric Hematology,Ankara,Turkey
,
Tiraje Celkan
Affiliations:
Cerrahpasa Universiry, Department of Pediatric Hematology, Istanbul,Turkey
,
Gul Nihal Ozdemir
Affiliations:
Cerrahpasa Universiry, Department of Pediatric Hematology, Istanbul,Turkey
,
Namik Ozbek
Affiliations:
3Ankara Çocuk Sagligi ve Hastalıklari Hematoloji Onkoloji Eğitim ve Arastırma Hastanesi, Ankara,Turkey
,
Nese Yarali
Affiliations:
Ankara Çocuk Sagligi ve Hastalıklari Hematoloji Onkoloji Eğitim ve Arastırma Hastanesi, Ankara,Turkey
,
Hasan Fatik Cakmakli
Affiliations:
Ankara Çocuk Sagligi ve Hastalıklari Hematoloji Onkoloji Eğitim ve Arastırma Hastanesi, Ankara,Turkey
,
Idil Yenicesu
Affiliations:
Gazi University, Department of Pediatric Hematology,Ankara,Turkey
,
Saliha Fatma Celik
Affiliations:
Hacettepe University, Medical Faculty, Ankara,Turkey
,
Hande Kizilocak
Affiliations:
Cerrahpasa Universiry, Department of Pediatric Hematology, Istanbul,Turkey
,
Muge Gokce
Affiliations:
Istanbul Saglik Bilimleri University, Department of Pediatric Hematology,Istanbul,Turkey
,
Naz Guleray
Affiliations:
Hacettepe University, Deparment of Medical Genetics,Ankara,Turkey
,
Mualla Cetin
Affiliations:
Hacettepe University, Divison Of Pediatric Hematology,Ankara,Turkey
,
Fatma Gumruk
Affiliations:
Hacettepe University, Divison Of Pediatric Hematology,Ankara,Turkey
Nurten Akarsu
Affiliations:
Hacettepe University, Deparment of Medical Genetics,Ankara,Turkey
(Abstract release date: 05/18/17) EHA Library. Unal S. 05/18/17; 182468; PB1754
Sule Unal
Sule Unal
Contributions
Abstract

Abstract: PB1754

Type: Publication Only

Background
Shwachman-Diamond syndrome (SDS) is an autosomal recessively inherited disease characterized with neutropenia, exocrine pancreas insufficiency, failure to thrive and skeletal abnormalities. In approximately 90% of the patients, the molecular defect is related to SBDS gene mutations. The classical triad is present in one-forth of the patients and a high degree of suspicion is required in order to make the diagnosis. In this study, molecular work-up to patients with suspected SDS were made and the clinical and laboratory findings that predict the SDS diagnosis were investigated.

Aims

Aim of the study was to find out the predictive clinical and laboratory characeteristics of SDS patients.

Methods
The patients who were sent to Hacettepe Inherited Bone Marrow Failure Center for molecular work-up between June 2015 and August 2016 were evaluated with clinical and laboratory data obtained from a standardized patient registry form.

Results
Molecular work-up was performed in 20 patients referred to our center with a suspected diagnosis of SDS. Of these 20 patients (12 girls), 4 (20%) (3 boys) were found to have mutation in SBDS gene. The median age of these patients was 3.2 years (1-18). Of the 4 patients with genetically verified SDS, 1 (25%) had history of chronic diarrhea and pancreas atrophy was detected in ultrasonography of that patient Another patient (25%) with SDS had skeletal abnormality, and 3 (75%) of the patientshad failure to thrive. Three patients (75%) had anemia associated to neutropenia, and 1 patient (25%) had pancytopenia at presentation. On the other hand of the patients who were referred with a suspicion of SDS but was found to have no mutation, 43% had neutropenia, 25% had bicytopenia, 10% had pancytopenia. The patientsin the latter group had failure to thrive in 25% of the patients and chronic or persistent diarrhea was present in 25% of this group. There was no statistically significant difference in the clinical and laboratory parameters of the genetically verified SDS patients and patients without SDS but was referred with SDS suspicion.

Conclusion

Although, there was no statistically significant difference in the clinical and laboratory parameters of the genetically verified SDS patients and patients without SDS but was referred with SDS suspicion, this might be attributed to the small sample sizes. Compatible with the previous literature data, SDS is a cryptic disorder and the classical triiad is not commonly fulfilled in most of the patients. On the other hand, failure to thrive/growth retardation was three times more common in patients with SDS. Thus, in patients neutropenia, accompanying failure to thrive/growth retardation might be an indicative to make molecular work-up for SDS. Additionally, not only neutropenia, but bicytopenia or pancytopenia might be the hematological presentational findings of SDS.

Session topic: 12. Bone marrow failure syndromes incl. PNH - Clinical

Keyword(s): Bone Marrow Failure

Abstract: PB1754

Type: Publication Only

Background
Shwachman-Diamond syndrome (SDS) is an autosomal recessively inherited disease characterized with neutropenia, exocrine pancreas insufficiency, failure to thrive and skeletal abnormalities. In approximately 90% of the patients, the molecular defect is related to SBDS gene mutations. The classical triad is present in one-forth of the patients and a high degree of suspicion is required in order to make the diagnosis. In this study, molecular work-up to patients with suspected SDS were made and the clinical and laboratory findings that predict the SDS diagnosis were investigated.

Aims

Aim of the study was to find out the predictive clinical and laboratory characeteristics of SDS patients.

Methods
The patients who were sent to Hacettepe Inherited Bone Marrow Failure Center for molecular work-up between June 2015 and August 2016 were evaluated with clinical and laboratory data obtained from a standardized patient registry form.

Results
Molecular work-up was performed in 20 patients referred to our center with a suspected diagnosis of SDS. Of these 20 patients (12 girls), 4 (20%) (3 boys) were found to have mutation in SBDS gene. The median age of these patients was 3.2 years (1-18). Of the 4 patients with genetically verified SDS, 1 (25%) had history of chronic diarrhea and pancreas atrophy was detected in ultrasonography of that patient Another patient (25%) with SDS had skeletal abnormality, and 3 (75%) of the patientshad failure to thrive. Three patients (75%) had anemia associated to neutropenia, and 1 patient (25%) had pancytopenia at presentation. On the other hand of the patients who were referred with a suspicion of SDS but was found to have no mutation, 43% had neutropenia, 25% had bicytopenia, 10% had pancytopenia. The patientsin the latter group had failure to thrive in 25% of the patients and chronic or persistent diarrhea was present in 25% of this group. There was no statistically significant difference in the clinical and laboratory parameters of the genetically verified SDS patients and patients without SDS but was referred with SDS suspicion.

Conclusion

Although, there was no statistically significant difference in the clinical and laboratory parameters of the genetically verified SDS patients and patients without SDS but was referred with SDS suspicion, this might be attributed to the small sample sizes. Compatible with the previous literature data, SDS is a cryptic disorder and the classical triiad is not commonly fulfilled in most of the patients. On the other hand, failure to thrive/growth retardation was three times more common in patients with SDS. Thus, in patients neutropenia, accompanying failure to thrive/growth retardation might be an indicative to make molecular work-up for SDS. Additionally, not only neutropenia, but bicytopenia or pancytopenia might be the hematological presentational findings of SDS.

Session topic: 12. Bone marrow failure syndromes incl. PNH - Clinical

Keyword(s): Bone Marrow Failure

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies